Gecosala, Joe-ana .
HRN: 26-42-68 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2024
CEFUROXIME 500MG (TAB)
12/27/2024
01/02/2025
PO
500 Mg
BID
Sp RMLE And Repair
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes